Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorErasmus Medical Center
About this trial
The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.
Eligibility criteria
Qualifiers
A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines;
Adults (=/>18 years).
Disqualifiers
Patients who are not able to speak, read and/or write in Dutch;
Patients with no access to the internet;
Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider;
Patients who are or have been using a home monitoring program for PF.
Trial design
Treatments tested in this trial
- Home monitoring care
Treatment groups
220 Participants
are divided into 2 treatment groupsSponsors and collaborators
Erasmus Medical Center
Lead sponsor
Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands
Collaborator
Leiden University Medical Center, LUMC, Leiden, The Netherlands
Collaborator
UMC Utrecht, Utrecht, the Netherlands
Collaborator
Rijnstate, Arnhem, the Netherlands
Collaborator
Catharina, Eindhoven, the Netherlands
Collaborator
MC Leeuwarden, Leeuwarden, the Netherlands
Collaborator
OLVG, Amsterdam, the Netherlands
Collaborator
Medical Center Haaglanden, The Hague, The Netherlands
Collaborator
Amphia, Breda, the Netherlands
Collaborator
St. Antonius Hospital
Collaborator
Source ClinicalTrials.gov